Current and Emerging CAR T-Cell Therapies in Cancer Care

Hear from the experts on how the latest clinical data inform the use of CAR T-cell therapies across hematologic malignancies. Review their insights with an on-demand webcast adapted from a live webinar along with downloadable slidesets 2 expert commentaries and a podcast.

Share

Program Content

Activities

CAR T Q&A
Expert Answers to HCP Questions on CAR T-Cell Therapy
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: July 19, 2021

Expires: July 18, 2022

Pearls: CAR T Q&A
Podcast Pearls: Expert Answers to HCP Questions on CAR T-Cell Therapy
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: July 19, 2021

Expires: July 18, 2022

No activities added yet

Activities

CAR T: Lymphomas
CAR T-Cell Therapy in Lymphoma: Current and Emerging Clinical Trial Evidence
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 16, 2021

Expires: June 15, 2022

CAR T: Myeloma
CAR T-Cell Therapies for Myeloma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 16, 2021

Expires: June 15, 2022

CAR T: ALL/Toxicities
CAR T-Cell Therapies for ALL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 16, 2021

Expires: June 15, 2022

<i>EP</i>: CAR T
ExpressPoints: Current and Emerging CAR T-Cell Therapies in Cancer Care
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 18, 2021

Expires: June 17, 2022

Activities

Delayed CAR T-Cell AEs
Identifying and Managing Delayed Adverse Events Associated With CAR T-Cell Therapy
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2021

Expires: August 04, 2022

CAR T for R/R MM
Adding Idecabtagene Vicleucel to the Treatment Armamentarium for Relapsed/Refractory Multiple Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 02, 2021

Expires: June 01, 2022

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb